Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01740687 · ClinicalTrials.gov registry record
A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test
A clinical trial, sponsored by Bayer.
- Completed
- Registry status
- 211
- Enrollment target
NCT01740687 is a clinical trial that has completed, run by Bayer. The registered enrollment target is 211 participants.
The verdict
NCT01740687 has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- 211 participants
- Enrollment target
Study Summary
The purpose of the post approval study is to evaluate the effectiveness and safety of the Essure System when a NovaSure Endometrial Ablation procedure is performed following a successful Essure Confirmation Test.
Interventions
- DEVICE ESS305 (Essure, BAY1454032)
- PROCEDURE NovaSure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 211 participants |
| Start Date | 2012-11-13 |
| Est. Completion | 2021-06-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01740687
The ClinicalTrials.gov registry entry for NCT01740687 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 211 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ESS305 (Essure, BAY1454032) is the first listed.
NCT01740687 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01740687 about?
NCT01740687 is a clinical study titled "A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test". The purpose of the post approval study is to evaluate the effectiveness and safety of the Essure System when a NovaSure Endometrial Ablation procedure is performed following a successful Essure Confirmation Test.
What is the current status of trial NCT01740687?
This trial is currently completed. The enrollment target is 211 participants. The study started on 2012-11-13. Estimated completion is 2021-06-14.
What interventions are being tested in trial NCT01740687?
The interventions under investigation include: ESS305 (Essure, BAY1454032) (DEVICE), NovaSure (PROCEDURE).
Who is sponsoring clinical trial NCT01740687?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.